Statement from the Council for Responsible Nutrition Regarding Peptides and Recent Press Coverage
JULY 27, 2026 — The recent Washington Post investigation and the New York Times opinion essay both raise legitimate concerns about the rapid growth of unapproved injectable peptide products and efforts to sidestep drug review of these products. CRN shares these concerns. Consumers deserve products that are backed by sound science and companies that comply with the law.
